Ionis Pharmaceuticals, Inc. (IONS)
After hours:
| Previous close | 48.15 |
| Open | 48.15 |
| Bid | 46.86 x 100 |
| Ask | 46.93 x 100 |
| Day's range | 46.26 - 48.56 |
| 52-week range | 35.95 - 54.44 |
| Volume | |
| Avg. volume | 1,307,182 |
| Market cap | 6.856B |
| Beta (5Y monthly) | 0.39 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.52 |
| Earnings date | 31 Oct 2024 - 04 Nov 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 62.40 |
ZacksWhy Is Zoetis (ZTS) Up 1.4% Since Last Earnings Report?
Zoetis (ZTS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ZacksTheravance Bio (TBPH) Up 2.2% Since Last Earnings Report: Can It Continue?
Theravance Bio (TBPH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
GlobeNewswirePraxis Precision Medicines to highlight their Epilepsy Portfolio at the International League Against Epilepsy 15th European Epilepsy Congress with six presentations
BOSTON, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that that it will present preclinical and clinical data from three of its epilepsy programs at the International League Against Epilepsy (ILAE) 15th European Epilepsy Congress (EEC), b
